When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CMRX - Chimerix to regain rights to antiviral candidate; shares up 3% after hours
Chimerix Inc.
Chimerix (NASDAQ:CMRX) discloses that licensee Contravir Pharmaceuticals (NASDAQ:CTRV) will terminate its license agreement for antiviral candidate CMX157 effective June 1 after deciding to stop development.
More news on: Chimerix, Inc., ContraVir Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,